The Universities of Giessen and Marburg Lung Center (UGMLC) is the coordinating site of the German Center for Lung Research (DZL - Deutsches Zentrum für Lungenforschung)
The Institute for Lung Health (ILH) is a joint institute of the Federal Government and the State of Hesse, embedded in the German Center for Lung Research (DZL), located at the Biomedical Research Campus of the Justus-Liebig University Giessen (JLU) and closely interlinked with the UGMLC
New study confirms the predictive power of risk models across different groups of pulmonary hypertension
A recent study published in the scientific journal CHEST, led by DZL scientists from the Institute for Lung Health (ILH) in Gießen, investigated the effectiveness of various risk models for predicting different forms of Pulmonary Hypertension (PH).
Lung cancer: An official research statement from the American Thoracic Society
Lung cancer remains the leading cause of cancer-related deaths in the U.S. and Europe. Despite available treatments, more than 70% of patients experience relapse and eventually succumb to the disease, often due to its spread to other parts of the body.
New Hope for PAH: Seralutinib Shows Promising Results
Pulmonary arterial hypertension (PAH) is a rare but serious condition characterized by high blood pressure in the arteries that connect the heart to the lungs. This disease leads to the narrowing and thickening of the arterial walls, which impairs blood flow and increases the pressure in the pulmonary arteries.
Our site uses cookies and similar technologies. By using the site, you consent to the use of cookies. You can find more information on this in our Privacy Policy.
.
